帕瑞昔布复合地佐辛用于下肢骨折急性疼痛的疗效观察  

Effect of Parecoxib Combine Decocine on Acute Pain During Fracture of Lower Limb

在线阅读下载全文

作  者:王仁儒[1] 陆立仁[1] 彭志勇[1] 梁秀萍[1] 彭为平[1] 刘芪东 

机构地区:[1]广东省佛山市南海区人民医院麻醉科,广东佛山528200

出  处:《中国医药指南》2012年第16期227-228,共2页Guide of China Medicine

摘  要:目的探讨帕瑞昔布复合地佐辛用于下肢骨折急性疼痛的临床效果。方法 ASA I^II下肢骨折患者50例,随机分为两组,帕瑞昔布+地佐辛(PD)组和咪达唑伦(M)组,观察记录入室时(T1)、用药后10min后(T2)、体位变动时(T3)的MAP、HR、SpO2,并在各时点进行疼痛视觉模拟评分法(VAS)评估患者疼痛程度。结果在T2、T3时间点中M组MAP、HR、VAS评分较PD组明显升高(P<0.05);在T1时间点两组间MAP、HR、VAS差异无统计学意义(P>0.05);各时间点两组间SpO2差异无统计学意义(P>0.05)。结论帕瑞昔布复合地佐辛能有效减轻下肢骨折患者引起的急性疼痛,而且临床安全性高。Objective To investigate the clinical effect of parecoxib composite decocine on acute pain during fracture of lower limb. Methods 50 ASA Ⅰ-Ⅱ patients undergoing fracture fixation operation of lower limb with combined spinal-epidural anesthesia were randomly divided into 2 groups: parecoxib composite deeocine group (PD) and midazolam group (M) . MAP, HR, SpO2 of all patients were observed at entering operating room (TI) , at 10minutes after dosage (T2) , at posture changing (T3) , and Visual Analogue Scale (VAS) were performed to all patients at above set point. Results MAP, HR, VAS showed significant difference between M group and PD group, M group was higher than PD group at T2, T3 (P〈0.05) . MAP, HR, VAS had no difference between M group and PD group at T1 (P〉0.05) . SpO2 was no difference between M group and PD group at all set piont (P〉0.05) . Conclusion Parecoxib composite decocine may relieved acute pain from fracture of lower limb, and the clinical safty is high.

关 键 词:帕瑞昔布 地佐辛 急性疼痛 下肢骨折 疗效 

分 类 号:R683.42[医药卫生—骨科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象